We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Novel Surgical Implant Kills Infection-Causing Bacteria Without Compromising Tissue Integration

By HospiMedica International staff writers
Posted on 24 Nov 2023
Print article
Image: Researchers tested the new 3D-printed material\'s resistance to fatigue (Photo courtesy of WSU Photo Services)
Image: Researchers tested the new 3D-printed material\'s resistance to fatigue (Photo courtesy of WSU Photo Services)

Around the world, numerous surgeries, including hip and knee replacements, are routinely performed. One major complication of these procedures is bacterial colonization on the implants, a primary factor leading to implant failure and adverse postoperative outcomes. Typically, the materials used in these implants, developed over half a century ago, lack inherent resistance to infections. While antibiotics are commonly used as a preventive measure, dangerous infections can still arise post-surgery or as delayed secondary infections. In cases where infections form a thin biofilm on the implant, systemic antibiotics are employed. However, approximately 7% of these surgeries require revision, involving implant removal, thorough cleaning, antibiotic treatment, and re-implantation.

Researchers at Washington State University (Pullman, WA, USA) have designed a new surgical implant that has demonstrated a remarkable 87% efficacy in eliminating staph infection-causing bacteria in lab tests. This breakthrough could significantly enhance infection control in various common surgical procedures. The research team utilized 3D printing technology to enhance a typical titanium alloy implant by integrating 10% tantalum, known for its corrosion resistance, and 3% copper. The copper component effectively ruptures the cell walls of most bacteria upon contact.

Moreover, the addition of tantalum promotes healthy cell integration and bone tissue growth, thus aiding in the patient’s recovery. The WSU researchers dedicated three years to a comprehensive examination of their implant prototype, analyzing its mechanical strength, biological compatibility, antibacterial effectiveness, and wear properties. This evaluation extended to both lab settings and animal model studies. A crucial aspect of their research was ensuring that metal ions from the implant do not erode into adjacent tissues, which could lead to toxicity. Moving forward, the team aims to improve the bacterial elimination rate to surpass the 99% standard without affecting tissue integration. Additionally, they are focusing on ensuring the implant's durability under real-life conditions, such as the demands of activities like hiking for knee replacement patients.

“Infection is a problem for which we do not have a solution,” said Amit Bandyopadhyay, Boeing Distinguished Professor in WSU’s School of Mechanical and Materials Engineering. “In most cases, the implant has no defensive power from the infection. We need to find something where the device material itself offers some inherent resistance — more than just providing drug-based infection control. Here we’re saying, why not change the material itself and have inherent antibacterial response from the material itself?”

Related Links:
Washington State University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Full Field Digital Mammography Phantom
Mammo FFDM Phantom

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.